PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Weekly Snapshots (July 25 – 29, 2022)

PharmaShots Weekly Snapshots (July 25 – 29, 2022)

July 29, 2022

BMS Failed to Meet its Primary Endpoint in P-III (CheckMate -914) Trial for Opdivo (nivolumab) + Yervoy (ipilimumab) as Adjuvant Treatment of Localized Renal Cell Carcinoma

BMS Failed to Meet its Primary Endpoint in P-III (CheckMate -914) Trial for Opdivo (nivolumab) + Yervoy (ipilimumab) as Adjuvant T...

July 29, 2022

Ionis Reports P-IIb (RE-THINC ESRD) Study Results of Fesomersen for the Treatment of End-Stage Renal Disease on Hemodialysis

Ionis Reports P-IIb (RE-THINC ESRD) Study Results of Fesomersen for the Treatment of End-Stage Renal Disease on Hemodialysis

July 29, 2022

NeuroSense Collaborated with NeuraLight to Advance ALS Oculometric Biomarkers Using AI and ML

NeuroSense Collaborated with NeuraLight to Advance ALS Oculometric Biomarkers Using AI and ML

July 29, 2022

AbbVie’s Rinvoq (upadacitinib) Receives EC’s Approval as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie’s Rinvoq (upadacitinib) Receives EC’s Approval as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloa...

July 29, 2022

Novartis’ Beovu (brolucizumab) Receives NICE Recommendation for Diabetic Macular Oedema

Novartis’ Beovu (brolucizumab) Receives NICE Recommendation for Diabetic Macular Oedema

July 29, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us